Development of an RT-RPA assay for La Crosse virus detection provides insights into age-dependent neuroinvasion in mice
Background La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and sero...
Gespeichert in:
| Veröffentlicht in: | Virology journal Jg. 22; H. 1; S. 95 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
09.04.2025
BioMed Central Ltd BMC |
| Schlagworte: | |
| ISSN: | 1743-422X, 1743-422X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility.
Methods
To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay’s analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR).
Results
Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals.
Conclusions
This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. |
|---|---|
| AbstractList | Background La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility. Methods To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay's analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR). Results Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals. Conclusions This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. Keywords: La Crosse virus, Reverse transcription recombinase polymerase amplification, Lateral flow assay, Neuroinvasion, Age-susceptible mouse model La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility. To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay's analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR). Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals. This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. Abstract Background La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility. Methods To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay’s analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR). Results Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals. Conclusions This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. BACKGROUND: La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility. METHODS: To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay’s analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR). RESULTS: Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals. CONCLUSIONS: This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. Background La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility. Methods To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay’s analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR). Results Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals. Conclusions This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility.BACKGROUNDLa Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility.To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay's analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR).METHODSTo address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay's analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR).Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals.RESULTSPrimer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals.This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies.CONCLUSIONSThis study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years. Early and accurate diagnosis is critical to reducing morbidity in this vulnerable population. However, existing molecular and serological methods are limited in sensitivity, specificity, and accessibility. To address these limitations, we developed a reverse transcription recombinase polymerase amplification (RT-RPA) assay for LACV detection. Primers targeting the divergent M segment of the LACV genome were designed and screened for optimal performance. The assay's analytical sensitivity was evaluated through serial dilutions of LACV RNA prior to reverse transcription, while specificity was assessed using reverse transcribed RNA from related or geographically relevant arboviruses. We further adapted the RT-RPA test into a lateral flow assay (LFA) format for potential point-of-care use. Additionally, we employed a murine model to explore the age-dependent dynamics of LACV neuroinvasion and clearance, with the virus detected using RT-RPA and reverse transcription quantitative polymerase change reaction (RT-qPCR). Primer screening identified an optimal primer pair that amplified LACV cDNA within 20 min at 39 °C, with a limit of detection (LOD) of 100 copies. The assay demonstrated high specificity, with no amplification of related or other geographically relevant arboviruses. Integration of the RT-RPA test into an LFA format preserved the LOD and specificity, enabling visual detection via test strips. In the murine model, weanling mice exhibited LACV neuroinvasion as early as 4 days post-infection (dpi), with sustained detection between 5 and 7 dpi. In adult mice, neuroinvasion was first detected at 5 dpi, plateauing between 6 and 10 dpi, and cleared entirely by 20 dpi in surviving animals. This study establishes the RT-RPA assay as an efficient, specific, and sensitive diagnostic platform for LACV, with potential for adaptation into field-deployable LFA tests. Moreover, our findings provide valuable insights into the age-dependent dynamics of LACV neuroinvasion and clearance, informing future diagnostic and therapeutic strategies. |
| ArticleNumber | 95 |
| Audience | Academic |
| Author | Tonto, Prince Baffour Alatrash, Reem Lumkong, Lily Sridhar, Sainetra Herrera, Bobby Brooke |
| Author_xml | – sequence: 1 givenname: Lily surname: Lumkong fullname: Lumkong, Lily organization: Rutgers Global Health Institute, Rutgers University, Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, Child Health Institute of New Jersey, Rutgers University – sequence: 2 givenname: Reem surname: Alatrash fullname: Alatrash, Reem organization: Rutgers Global Health Institute, Rutgers University, Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, Child Health Institute of New Jersey, Rutgers University – sequence: 3 givenname: Sainetra surname: Sridhar fullname: Sridhar, Sainetra organization: Rutgers Global Health Institute, Rutgers University, Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, Child Health Institute of New Jersey, Rutgers University – sequence: 4 givenname: Prince Baffour surname: Tonto fullname: Tonto, Prince Baffour organization: Rutgers Global Health Institute, Rutgers University, Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, Child Health Institute of New Jersey, Rutgers University – sequence: 5 givenname: Bobby Brooke surname: Herrera fullname: Herrera, Bobby Brooke email: bherrera@globalhealth.rutgers.edu organization: Rutgers Global Health Institute, Rutgers University, Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, Child Health Institute of New Jersey, Rutgers University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40205618$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl2L1DAUhousuB_6B7yQgDd60TUfbZNeyTB-DQwo4wrehbQ56WbpJGPSjs6_N92uyw6IpoQc0ud9yzl9z7MT5x1k2XOCLwkR1ZtIaC3KHNNpc4rzw6PsjPCC5QWl308e1KfZeYw3GDNa8fpJdlpgisuKiLPs5zvYQ-93W3AD8gYphzZX-ebLAqkY1QEZH9BaoWXwMQLa2zBGpGGAdrDeoV3we6shIuui7a6HqRg8Uh3kGnbg9OTqYAzeur2Kk8Q6tLUtPM0eG9VHeHZ3XmTfPry_Wn7K158_rpaLdd5WGA-5AFXyklalKBnlBnNemFZUghlTYyVSg1BAo2nFSEMMYI6B41a1nJnGNEXFLrLV7Ku9upG7YLcqHKRXVt5e-NBJFQbb9iDTdBqllSk5JwXoUtVNqYQu02QJrmuVvN7OXrux2YJuU3NB9Uemx2-cvZad30tCalGQiiSHV3cOwf8YIQ5ya2MLfa8c-DFKRnFFCSMl_j9KhCgSz-qEvpzRTqU2rDM-fb2dcLkQrKgJTitRl3-h0qMh_ZCULGPT_ZHg9ZEgMQP8Gjo1xihXXzfH7IuHo7mfyZ-gJYDOQDslKYC5RwiWU5rlnGaZ0ixv0ywPScRmUUyw6yDIGz8Gl_LyL9Vvi572Bw |
| Cites_doi | 10.1016/j.jviromet.2021.114227 10.1001/jamanetworkopen.2021.26931 10.3390/v11090794 10.3201/eid2504.181016 10.1038/s41598-024-81763-7 10.1038/s41467-020-19258-y 10.1371/journal.ppat.1010384 10.1038/s41598-021-95757-2 10.1186/1743-422X-5-25 10.1093/jme/tjad090 10.1128/jcm.32.9.2076-2080.1994 10.1038/s41598-020-77692-w 10.1128/JVI.01866-14 10.1038/s41467-022-28428-z 10.1038/s41467-023-37833-x 10.1186/1743-422X-5-164 10.3390/v14030468 10.4269/ajtmh.23-0160 10.1371/journal.pntd.0011065 10.1371/journal.pntd.0010311 10.1016/j.virol.2010.04.012 10.1017/S0950268818003096 10.1373/clinchem.2015.245829 10.3389/fitd.2021.707865 10.1016/S0891-5520(05)70410-4 10.1016/j.amjmed.2016.03.021 10.1099/jgv.0.001083 10.3390/v16030483 10.1128/JVI.79.1.234-244.2005 10.1093/ofid/ofx150 10.1016/j.mam.2005.12.001 10.1038/s41564-020-0714-0 10.1371/journal.pone.0006145 10.1186/s12974-021-02173-4 10.1101/2025.02.25.640063 10.1542/peds.2014-0498 10.1128/JVI.01933-06 10.1186/1743-422X-4-41 10.1016/j.trac.2017.10.015 10.1128/JCM.43.4.1885-1889.2005 10.1038/s41598-021-82479-8 10.1128/jvi.01762-24 10.1038/srep37732 10.1093/cid/ciac403 10.1128/jcm.23.4.667-671.1986 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. The Author(s) 2025 2025 |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: The Author(s) 2025 2025 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1186/s12985-025-02720-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Open Access: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1743-422X |
| EndPage | 95 |
| ExternalDocumentID | oai_doaj_org_article_032badaf57714ed5a9b5a8d57201099a PMC11984161 A834910000 40205618 10_1186_s12985_025_02720_y |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States North America |
| GeographicLocations_xml | – name: United States – name: North America |
| GrantInformation_xml | – fundername: New Jersey Health Foundation grantid: IFH18-24 funderid: https://doi.org/10.13039/100001774 – fundername: New Jersey Health Foundation grantid: IFH18-24 |
| GroupedDBID | --- 0R~ 123 29Q 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAHBH AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LGEZI LOTEE M1P M~E NADUK NXXTH O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c600t-8ea57526585327f0774fc8683ff90a8174e4ebd2631b1fe070e70cac73fbfb463 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001462628400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1743-422X |
| IngestDate | Fri Oct 03 12:51:09 EDT 2025 Tue Nov 04 02:06:00 EST 2025 Fri Nov 14 18:44:52 EST 2025 Fri Sep 05 17:41:27 EDT 2025 Sat Nov 29 13:51:00 EST 2025 Sat Nov 29 10:32:50 EST 2025 Thu Nov 13 15:56:25 EST 2025 Mon Jul 21 05:59:42 EDT 2025 Sat Nov 29 08:02:17 EST 2025 Sat Sep 06 07:30:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Lateral flow assay Neuroinvasion La Crosse virus Reverse transcription recombinase polymerase amplification Age-susceptible mouse model |
| Language | English |
| License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c600t-8ea57526585327f0774fc8683ff90a8174e4ebd2631b1fe070e70cac73fbfb463 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/032badaf57714ed5a9b5a8d57201099a |
| PMID | 40205618 |
| PQID | 3188432039 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_032badaf57714ed5a9b5a8d57201099a pubmedcentral_primary_oai_pubmedcentral_nih_gov_11984161 proquest_miscellaneous_3206213150 proquest_miscellaneous_3188432039 gale_infotracmisc_A834910000 gale_infotracacademiconefile_A834910000 gale_incontextgauss_ISR_A834910000 pubmed_primary_40205618 crossref_primary_10_1186_s12985_025_02720_y springer_journals_10_1186_s12985_025_02720_y |
| PublicationCentury | 2000 |
| PublicationDate | 2025-04-09 |
| PublicationDateYYYYMMDD | 2025-04-09 |
| PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-09 day: 09 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Virology journal |
| PublicationTitleAbbrev | Virol J |
| PublicationTitleAlternate | Virol J |
| PublicationYear | 2025 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | L Lau (2720_CR16) 2017; 4 SS Soldan (2720_CR3) 2005; 79 S Harding (2720_CR18) 2018; 147 AB Evans (2720_CR28) 2021; 11 G Blakqori (2720_CR4) 2007; 81 2720_CR27 JT Gaensbauer (2720_CR14) 2014; 134 NI Vasileva Wand (2720_CR31) 2018; 99 AD Haddow (2720_CR12) 2009; 4 KG Taylor (2720_CR38) 2014; 88 T Goldman (2720_CR11) 2024; 110 J Davis (2720_CR37) 2024; 85 M Jauset-Rubio (2720_CR34) 2016; 6 AB Evans (2720_CR40) 2022; 18 CA Day (2720_CR19) 2023; 60 RS Bennett (2720_CR39) 2008; 5 A Harmon (2720_CR42) 2021; 4 AJ Lambert (2720_CR26) 2005; 43 J Qian (2720_CR41) 2020; 11 2720_CR47 RK Daher (2720_CR29) 2016; 62 TC Pierson (2720_CR46) 2020; 5 SS Soldan (2720_CR5) 2010; 404 AB Evans (2720_CR15) 2019; 25 DK Ghosh (2720_CR36) 2020; 10 CH Calisher (2720_CR45) 1986; 23 F Watzinger (2720_CR25) 2006; 27 CA Day (2720_CR9) 2023; 17 JE McJunkin (2720_CR10) 1998; 12 IM Lobato (2720_CR32) 2018; 98 N Salcedo (2720_CR43) 2021; 2 R Basu (2720_CR20) 2023; 14 LP Wasieloski Jr (2720_CR24) 1994; 32 B Arragain (2720_CR8) 2022; 13 R Basu (2720_CR22) 2021; 18 TR Shelite (2720_CR35) 2021; 296 N Salcedo (2720_CR44) 2022; 16 2720_CR1 2720_CR2 2720_CR33 SM Reese (2720_CR6) 2008; 5 2720_CR13 R Alatrash (2720_CR21) 2024; 98 M Faye (2720_CR30) 2021; 11 AE Boutzoukas (2720_CR17) 2023; 76 AL Teleron (2720_CR23) 2016; 129 RS Bennett (2720_CR7) 2007; 4 |
| References_xml | – volume: 296 start-page: 114227 year: 2021 ident: 2720_CR35 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2021.114227 – volume: 4 start-page: e2126931 issue: 8 year: 2021 ident: 2720_CR42 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.26931 – ident: 2720_CR2 doi: 10.3390/v11090794 – volume: 25 start-page: 728 issue: 4 year: 2019 ident: 2720_CR15 publication-title: Emerg Infect Dis doi: 10.3201/eid2504.181016 – ident: 2720_CR33 doi: 10.1038/s41598-024-81763-7 – volume: 11 start-page: 5920 issue: 1 year: 2020 ident: 2720_CR41 publication-title: Nat Commun doi: 10.1038/s41467-020-19258-y – volume: 18 start-page: e1010384 issue: 3 year: 2022 ident: 2720_CR40 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1010384 – volume: 11 start-page: 16424 issue: 1 year: 2021 ident: 2720_CR28 publication-title: Sci Rep doi: 10.1038/s41598-021-95757-2 – volume: 5 start-page: 25 year: 2008 ident: 2720_CR39 publication-title: Virol J doi: 10.1186/1743-422X-5-25 – volume: 60 start-page: 1165 issue: 6 year: 2023 ident: 2720_CR19 publication-title: J Med Entomol doi: 10.1093/jme/tjad090 – volume: 32 start-page: 2076 issue: 9 year: 1994 ident: 2720_CR24 publication-title: J Clin Microbiol doi: 10.1128/jcm.32.9.2076-2080.1994 – ident: 2720_CR13 – volume: 10 start-page: 20593 issue: 1 year: 2020 ident: 2720_CR36 publication-title: Sci Rep doi: 10.1038/s41598-020-77692-w – volume: 88 start-page: 11070 issue: 19 year: 2014 ident: 2720_CR38 publication-title: J Virol doi: 10.1128/JVI.01866-14 – volume: 13 start-page: 902 issue: 1 year: 2022 ident: 2720_CR8 publication-title: Nat Commun doi: 10.1038/s41467-022-28428-z – volume: 14 start-page: 2836 issue: 1 year: 2023 ident: 2720_CR20 publication-title: Nat Commun doi: 10.1038/s41467-023-37833-x – volume: 5 start-page: 164 year: 2008 ident: 2720_CR6 publication-title: Virol J doi: 10.1186/1743-422X-5-164 – ident: 2720_CR27 doi: 10.3390/v14030468 – volume: 110 start-page: 850 issue: 5 year: 2024 ident: 2720_CR11 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.23-0160 – volume: 17 start-page: e0011065 issue: 1 year: 2023 ident: 2720_CR9 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0011065 – volume: 16 start-page: e0010311 issue: 3 year: 2022 ident: 2720_CR44 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0010311 – volume: 404 start-page: 139 issue: 2 year: 2010 ident: 2720_CR5 publication-title: Virology doi: 10.1016/j.virol.2010.04.012 – volume: 147 start-page: e66 year: 2018 ident: 2720_CR18 publication-title: Epidemiol Infect doi: 10.1017/S0950268818003096 – volume: 62 start-page: 947 issue: 7 year: 2016 ident: 2720_CR29 publication-title: Clin Chem doi: 10.1373/clinchem.2015.245829 – volume: 2 start-page: 707865 year: 2021 ident: 2720_CR43 publication-title: Front Trop Dis doi: 10.3389/fitd.2021.707865 – volume: 12 start-page: 83 issue: 1 year: 1998 ident: 2720_CR10 publication-title: Infect Dis Clin North Am doi: 10.1016/S0891-5520(05)70410-4 – volume: 129 start-page: 881 issue: 8 year: 2016 ident: 2720_CR23 publication-title: Am J Med doi: 10.1016/j.amjmed.2016.03.021 – volume: 99 start-page: 1012 issue: 8 year: 2018 ident: 2720_CR31 publication-title: J Gen Virol doi: 10.1099/jgv.0.001083 – ident: 2720_CR1 doi: 10.3390/v16030483 – volume: 79 start-page: 234 issue: 1 year: 2005 ident: 2720_CR3 publication-title: J Virol doi: 10.1128/JVI.79.1.234-244.2005 – volume: 4 start-page: ofx150 issue: 3 year: 2017 ident: 2720_CR16 publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofx150 – volume: 27 start-page: 254 issue: 2–3 year: 2006 ident: 2720_CR25 publication-title: Mol Aspects Med doi: 10.1016/j.mam.2005.12.001 – volume: 5 start-page: 796 issue: 6 year: 2020 ident: 2720_CR46 publication-title: Nat Microbiol doi: 10.1038/s41564-020-0714-0 – volume: 4 start-page: e6145 issue: 7 year: 2009 ident: 2720_CR12 publication-title: PLoS ONE doi: 10.1371/journal.pone.0006145 – volume: 18 start-page: 125 issue: 1 year: 2021 ident: 2720_CR22 publication-title: J Neuroinflammation doi: 10.1186/s12974-021-02173-4 – ident: 2720_CR47 doi: 10.1101/2025.02.25.640063 – volume: 134 start-page: e642 issue: 3 year: 2014 ident: 2720_CR14 publication-title: Pediatrics doi: 10.1542/peds.2014-0498 – volume: 81 start-page: 4991 issue: 10 year: 2007 ident: 2720_CR4 publication-title: J Virol doi: 10.1128/JVI.01933-06 – volume: 4 start-page: 41 year: 2007 ident: 2720_CR7 publication-title: Virol J doi: 10.1186/1743-422X-4-41 – volume: 98 start-page: 19 year: 2018 ident: 2720_CR32 publication-title: Trends Analyt Chem doi: 10.1016/j.trac.2017.10.015 – volume: 85 start-page: 289 issue: 4 year: 2024 ident: 2720_CR37 publication-title: N C Med J – volume: 43 start-page: 1885 issue: 4 year: 2005 ident: 2720_CR26 publication-title: J Clin Microbiol doi: 10.1128/JCM.43.4.1885-1889.2005 – volume: 11 start-page: 3131 issue: 1 year: 2021 ident: 2720_CR30 publication-title: Sci Rep doi: 10.1038/s41598-021-82479-8 – volume: 98 start-page: e0176224 issue: 12 year: 2024 ident: 2720_CR21 publication-title: J Virol doi: 10.1128/jvi.01762-24 – volume: 6 start-page: 37732 year: 2016 ident: 2720_CR34 publication-title: Sci Rep doi: 10.1038/srep37732 – volume: 76 start-page: e1114 issue: 3 year: 2023 ident: 2720_CR17 publication-title: Clin Infect Dis doi: 10.1093/cid/ciac403 – volume: 23 start-page: 667 issue: 4 year: 1986 ident: 2720_CR45 publication-title: J Clin Microbiol doi: 10.1128/jcm.23.4.667-671.1986 |
| SSID | ssj0032679 |
| Score | 2.4096642 |
| Snippet | Background
La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under... La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under 16 years.... Background La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children under... BACKGROUND: La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting children... Abstract Background La Crosse virus (LACV) is a mosquito-borne arbovirus responsible for pediatric encephalitis in North America, predominantly affecting... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 95 |
| SubjectTerms | adults Age Factors Age factors in disease Age-susceptible mouse model Analysis animal models Animals Arbovirus diseases arboviruses at-risk population Biochemical assays Biomedical and Life Sciences Biomedicine California encephalitis orthobunyavirus Central nervous system diseases Complications and side effects detection limit Diagnosis Disease Models, Animal DNA Primers - genetics Encephalitis Encephalitis, California - diagnosis Encephalitis, California - virology Female Genetic transcription genome Genomics Health aspects La Crosse virus La Crosse virus - genetics La Crosse virus - isolation & purification Lateral flow assay Methods Mice Molecular diagnostic techniques morbidity Neuroinvasion North America Nucleic Acid Amplification Techniques - methods oligodeoxyribonucleotides point-of-care systems recombinase polymerase amplification reverse transcription Reverse transcription recombinase polymerase amplification Risk factors RNA RNA, Viral - genetics Sensitivity and Specificity therapeutics Virology weanlings |
| SummonAdditionalLinks | – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BeYgLj_IKFGQQEgcakYcTO8elogKpVNW2oN4sO7HLHnDQOrto_z1jJ6magirBYaXVevYwk3l8k3kY4A1r6sxISuNCJTqmLEGTKjBrNRXN69IojJhhiesBOzzkp6fV0TAU5sZu97EkGTx1MGtevncYmbifJvYfhknP5jrcwHDHvTnOj7-N_hfxCKvG8Zi__m8SgsKm_j_98YWAdLlZ8lLFNASi_Xv_x8J9uDsATzLrNeUBXNN2G271V1FutuH2l6HI_hB-XWgkIq0h0pL5STw_mhEE2nJDEOaSA0n2PHOarBfLlSON7kJPlyXDaJ8jC-t84u-_dC1BtxWPF-52JGzRXNi19O_qkID8QH_1CL7ufzzZ-xQP9zPENcKkLuZaItjLEMMUecZMgkjS1LzkuTFVIjnmOppq1WRlnqrUaHQumiW1rFlulFG0zB_Dlm2tfgqEKlOnRaMKg3BD80oxXjJ0vZwWvMGTCN6Nj0z87NdwiJC-8FL0UhUoVRGkKjYRfPBP9ZzSr9AOP7TLMzFYpEBFUbKRpmAspbopZKUKyZuCZaFaKCN47XVC-CUZ1nfhnMmVc-Lz8VzMeE6rUBiJ4O1AZFrUDmSuH2pArvxerQnlzoQSrbieHL8aVU_4I9_6ZnW7cgKdLqd5luTVFTRZUmZpjuA-gie9up4z718QIEjmEfCJIk-kMz2xi-9h0XiaVr4qnUawO-qzGFycu0L8z_6N_DncyYJJ0DipdmCrW670C7hZr7uFW74Mtv0bCidLPA priority: 102 providerName: Springer Nature |
| Title | Development of an RT-RPA assay for La Crosse virus detection provides insights into age-dependent neuroinvasion in mice |
| URI | https://link.springer.com/article/10.1186/s12985-025-02720-y https://www.ncbi.nlm.nih.gov/pubmed/40205618 https://www.proquest.com/docview/3188432039 https://www.proquest.com/docview/3206213150 https://pubmed.ncbi.nlm.nih.gov/PMC11984161 https://doaj.org/article/032badaf57714ed5a9b5a8d57201099a |
| Volume | 22 |
| WOSCitedRecordID | wos001462628400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: RBZ dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Open Access: DOAJ - Directory of Open Access Journals customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: M~E dateStart: 20040101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: AUTh Library subscriptions: ProQuest Central customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1743-422X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032679 issn: 1743-422X databaseCode: RSV dateStart: 20041201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED_B-BAvCMZXYFQGIfEA0ZLYiZ3HbtrEpK2quoHKk2UnNvQlRU1a1P-es5NMzZDGCw-NmvgqxXfnu9_1zmeAD7wsEqsYC1MdmZDxCJdUilGrzRktMqvRY_omrud8MhHzeT7dOerL1YS17YFbxh1GNNGqVDblPGamTFWuUyXKlCc-qeOhEaKePphqbTBiEp73W2REdlijVxNuJ7L74C_D7cAN-W79f9vkHad0s2DyRtbUO6PTJ_C4Q5Fk3L79U7hjqn140J4rud2HhxddxvwZ_N6pCiJLS1RFZlfhbDomiJrVliBmJeeKHLu3NGSzWK1rUprGF2hVpNunV5NFVbso3n1plgRtUNifntsQ3xJzUW2U--MNCYg74f45fD09uTr-EnaHLYQFYp4mFEYhcksQkKQ04TZCWGgLkQlqbR4pgYGLYUaXSUZjHVuDlsLwqFAFp1ZbzTL6AvaqZWVeAWHaFnFa6tQidjAi11xkHO2oYKkocSSATz3v5a-2p4b0sYjIZCspiZKSXlJyG8CRE881peuH7R-glshOS-S_tCSA90640nW8qFxJzQ-1rmt5djmTY0FZ7rMcAXzsiOwSxYyTa3co4Kxck6wB5cGAEpdkMRh-1-uQdEOujq0yy3Ut0YIKRpOI5rfQJFGWxBSRegAvW727nryL9hHxigDEQCMH3BmOVIufvmt4HOcuxRwH8LlXXtnZq_oW9r_-H-x_A48Sv_hYGOUHsNes1uYt3C82zaJejeAun3N_FSO4d3Qymc5Gfjnj3fTsYvod72aX3_4A52hMdQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BeV54lFeggEFIPUBEHk7sHJeKqhXbVbVdUG-WndglBxK0yS7af8_YSaqmoEpwWGm1nj3MZB7fZB4GeMeKPDKSUj9RgfYpC9CkEsxaTUbjPDUKI6Zb4jplsxk_Pc2O-6GwZuh2H0qSzlM7s-bpxwYjE7fTxPbDMOnZXIcbFCOWbeSbn3wb_C_iEZYN4zF__d8oBLlN_X_64wsB6XKz5KWKqQtE-_f_j4UHcK8HnmTSacpDuKarbbjVXUW52YbbR32R_RH8utBIRGpDZEXmC39-PCEItOWGIMwlU0n2LHOarMvlqiGFbl1PV0X60b6GlFVjE3_7pa0Jui1_uHC3JW6LZlmtpX1XhwTkB_qrx_B1__Ni78Dv72fwc4RJrc-1RLAXIYZJ4oiZAJGkyXnKY2OyQHLMdTTVqojSOFSh0ehcNAtymbPYKKNoGj-Braqu9DMgVJk8TAqVGIQbmmeK8ZSh6-U04QWeePB-eGTiZ7eGQ7j0haeik6pAqQonVbHx4JN9queUdoW2-6FenoneIgUqipKFNAljIdVFIjOVSF4kLHLVQunBW6sTwi7JqGwXzplcNY04PJmLCY9p5gojHuz2RKZG7UDmuqEG5Mru1RpR7owo0Yrz0fGbQfWEPbKtb5WuV41Ap8tpHAVxdgVNFKRRGCO49-Bpp67nzNsXBAiSuQd8pMgj6YxPqvK7WzQehpmtSocefBj0WfQurrlC_M__jfw13DlYHE3F9HD25QXcjZx5UD_IdmCrXa70S7iZr9uyWb5ydv4bkWlOIA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BgYoLj_IKFDAIiQNEzcOJneNSWFGxrFbbgnqz7MQueyCpNtlF--8ZO0m1KagS4rBStJ4cPJnHN56HAd6wIo-MpNRPVKB9ygJUqQSjVpPROE-NQo_phrhO2HTKT0-z2VYXv6t271OSbU-DndJUNgfnhWlVnKcHNXopbjuL7Y9hALS5DjeovTTIxuvH33tbjNiEZX2rzF_fG7gjN7X_T9u85ZwuF05eyp46pzS--__buQd3OkBKRq0E3YdrutyDW-0VlZs92P3aJd8fwK-tAiNSGSJLMj_x57MRQQAuNwThL5lIcmg3qsl6sVzVpNCNq_UqSdfyV5NFWdsDAfvQVATNmd9fxNsQN11zUa6lPcNDAvIT7dhD-Db-dHL42e_ubfBzhE-Nz7VEEBghtkniiJkAEabJecpjY7JAcoyBNNWqiNI4VKHRaHQ0C3KZs9goo2gaP4Kdsir1EyBUmTxMCpUYhCGaZ4rxlKFJ5jThBa548K7_fOK8Hc8hXFjDU9FyVSBXheOq2HjwwX7hC0o7Wtv9US3PRKepAoVGyUKahLGQ6iKRmUokLxIWuSyi9OC1lQ9hh2eUtjrnTK7qWhwdz8WIxzRzCRMP3nZEpkJJwc21zQ64Kztva0C5P6BE7c4Hy696MRR2yZbElbpa1QKNMadxFMTZFTRRkEZhjKDfg8et6F5s3h4cIHjmHvCBUA-4M1wpFz_cAPIwzGy2OvTgfS_bojN99RXsf_pv5C9hd_ZxLCZH0y_P4HbktIP6QbYPO81ypZ_DzXzdLOrlC6fyvwEb_FcE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+an+RT-RPA+assay+for+La+Crosse+virus+detection+provides+insights+into+age-dependent+neuroinvasion+in+mice&rft.jtitle=Virology+journal&rft.au=Lumkong%2C+Lily&rft.au=Alatrash%2C+Reem&rft.au=Sridhar%2C+Sainetra&rft.au=Tonto%2C+Prince+Baffour&rft.date=2025-04-09&rft.issn=1743-422X&rft.eissn=1743-422X&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12985-025-02720-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12985_025_02720_y |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon |